Javascript must be enabled to continue!
Opioid agonist and antagonist behavioural effects of buprenorphine
View through CrossRef
The agonist and antagonist effects of a range of bupenorphine doses (0.08–20 mg/kg) were studied on the responding of pigeons under a multiple fixed‐ratio, fixed‐interval schedule of grain presentation. Various doses (0.02–10 mg/kg) of buprenorphine were also tested in pigeons trained to discriminate between injections of 0.05 mg/kg of fentanyl and injections of distilled water.
Buprenorphine, over a broad dose range (0.08–5 mg/kg), increased the rates of responding in the fixed‐interval component of the multiple schedule and disrupted patterning of responding within the fixed‐interval, without affecting fixed‐ratio responding even at a dose of 40 mg/kg. The effects of some of the high doses on fixed‐interval responding were still evident one and two days after buprenorphine injection.
Doses of buprenorphine which produced increases in fixed‐interval responding were also effective as antagonists of the behavioural depression produced by 40 mg/kg of morphine, and were discriminated as fentanyl‐like by pigeons trained to discriminate between injections of fentanyl and injections of water.
These results show that buprenorphine produces marked agonist and antagonist effects over an extremely broad dose range without producing behavioural depressant effects.
Title: Opioid agonist and antagonist behavioural effects of buprenorphine
Description:
The agonist and antagonist effects of a range of bupenorphine doses (0.
08–20 mg/kg) were studied on the responding of pigeons under a multiple fixed‐ratio, fixed‐interval schedule of grain presentation.
Various doses (0.
02–10 mg/kg) of buprenorphine were also tested in pigeons trained to discriminate between injections of 0.
05 mg/kg of fentanyl and injections of distilled water.
Buprenorphine, over a broad dose range (0.
08–5 mg/kg), increased the rates of responding in the fixed‐interval component of the multiple schedule and disrupted patterning of responding within the fixed‐interval, without affecting fixed‐ratio responding even at a dose of 40 mg/kg.
The effects of some of the high doses on fixed‐interval responding were still evident one and two days after buprenorphine injection.
Doses of buprenorphine which produced increases in fixed‐interval responding were also effective as antagonists of the behavioural depression produced by 40 mg/kg of morphine, and were discriminated as fentanyl‐like by pigeons trained to discriminate between injections of fentanyl and injections of water.
These results show that buprenorphine produces marked agonist and antagonist effects over an extremely broad dose range without producing behavioural depressant effects.
Related Results
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Assessing the Safety and Efficacy of Converting Adults with Sickle Cell Disease from Full Agonist Opioids to Buprenorphine
Abstract
Background: The management of pain in adults with sickle cell disease (SCD) is complex, with the intermingling of both acute vaso-occlusive events and chron...
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
A prospective, randomized trial of the effect of buprenorphine continuation versus dose reduction on pain control and post-operative opioid use
Introduction:
An increasing number of individuals are taking buprenorphine for management of opioid use disorder (OUD). Pain control can be challenging when these patie...
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
The Effects of Prenatal Buprenorphine Exposure on the Neurobehavioral Development of the Child
Background: Current guidelines for pregnant women with substance use disorder advise prenatal maintenance of opioid agonist therapy with either buprenorphine or methadone. Despite ...
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
Buprenorphine-Precipitated Withdrawal Among Hospitalized Patients Using Fentanyl
ImportanceBuprenorphine treatment of opioid use disorder (OUD) is safe and effective, but opioid withdrawal during treatment initiation is associated with poor retention in care. A...
Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Long-Term Buprenorphine Treatment for Kratom use Disorder: A Case Series
Background: Opioid agonist therapy with buprenorphine is an effective, evidence-based treatment for opioid use disorder. However, there has been increasing use of alternative subst...
A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids
A Large-Scale Observational Study on the Temporal Trends and Risk Factors of Opioid Overdose: Real-World Evidence for Better Opioids
Abstract
Background
The United States is in the midst of an opioid overdose epidemic. We evaluated the temporal trends and risk...
Trends in Access to Medications for Opioid Use Disorder
Trends in Access to Medications for Opioid Use Disorder
ImportanceMedicaid, the largest payer for medications for opioid use disorder (MOUD), disenrolled more than 19.1 million individuals by March 2024 after the continuous coverage req...
Perioperative pain management and outcomes in patients who discontinued or continued pre-existing buprenorphine therapy
Perioperative pain management and outcomes in patients who discontinued or continued pre-existing buprenorphine therapy
Objective: This study compared opioid utilization and clinical outcomes in surgical patients receiving maintenance buprenorphine therapy who discontinued versus those who continued...

